Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement
Authors
Keywords
-
Journal
NEUROPHARMACOLOGY
Volume 239, Issue -, Pages 109685
Publisher
Elsevier BV
Online
2023-08-13
DOI
10.1016/j.neuropharm.2023.109685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
- (2023) Jessica M. Illenberger et al. Frontiers in Pharmacology
- Sex- and Dose-Dependent Differences in the Development of an Addiction-Like Phenotype Following Extended-Access Fentanyl Self-Administration
- (2022) Eleanor Blair Towers et al. Frontiers in Pharmacology
- The orexin story, sleep and sleep disturbances
- (2022) Fabio Pizza et al. JOURNAL OF SLEEP RESEARCH
- Alternative use of suvorexant (Belsomra®) for the prevention of alcohol drinking and seeking in rats with a history of alcohol dependence
- (2022) Francisco J. Flores-Ramirez et al. Frontiers in Behavioral Neuroscience
- Daridorexant, a recently approved Dual Orexin Receptor Antagonists (DORA) in the treatment of insomnia
- (2022) Dwaipayan Sarathi Chakraborty et al. Current Drug Research Reviews
- A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse
- (2021) Anousheh Bakhti-Suroosh et al. PSYCHOPHARMACOLOGY
- Paradoxical changes in brain reward status during oxycodone self‐administration in a novel test of the negative reinforcement hypothesis
- (2021) Jacques D. Nguyen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
- (2020) Morgan H. James et al. NEUROPSYCHOPHARMACOLOGY
- Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats
- (2020) Adam Kimbrough et al. PSYCHOPHARMACOLOGY
- Bidirectional relationship between opioids and disrupted sleep: putative mechanisms
- (2020) D. Eacret et al. MOLECULAR PHARMACOLOGY
- Female and male rats readily consume and prefer oxycodone to water in a chronic, continuous access, two-bottle oral voluntary paradigm
- (2020) Giulia Zanni et al. NEUROPHARMACOLOGY
- Effects of orexin receptor antagonism on human sleep architecture: A systematic review
- (2020) Jacob W. Clark et al. SLEEP MEDICINE REVIEWS
- Intermittent self‐administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system
- (2020) Jennifer E. Fragale et al. ADDICTION BIOLOGY
- Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
- (2020) George F. Koob PHARMACOLOGICAL REVIEWS
- The role of orexin-1 receptor signaling in demand for the opioid fentanyl
- (2019) Jennifer E. Fragale et al. NEUROPSYCHOPHARMACOLOGY
- Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia and Negative Reinforcement
- (2019) George F. Koob BIOLOGICAL PSYCHIATRY
- Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
- (2019) Aida Mohammadkhani et al. BRAIN RESEARCH
- PSPH-D-18-00526: Effect of a dual orexin receptor antagonist (DORA-12) on sleep and event-related oscillations in rats exposed to ethanol vapor during adolescence
- (2019) Cindy L. Ehlers et al. PSYCHOPHARMACOLOGY
- Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
- (2019) Ying Han et al. Neuroscience Bulletin
- Sex differences in oral oxycodone self‐administration and stress‐primed reinstatement in rats
- (2019) Hannah D. Fulenwider et al. ADDICTION BIOLOGY
- Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats
- (2019) Alessandra Matzeu et al. NEUROPHARMACOLOGY
- Sleep Management Among Patients with Substance Use Disorders
- (2018) Subhajit Chakravorty et al. MEDICAL CLINICS OF NORTH AMERICA
- Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy
- (2018) Thomas C. Thannickal et al. Science Translational Medicine
- Sex differences in daily life stress and craving in opioid-dependent patients
- (2018) Landhing M. Moran et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
- (2018) Erin J. Campbell et al. BRAIN RESEARCH
- Prevention and Treatment of Opioid Misuse and Addiction
- (2018) Nora D. Volkow et al. JAMA Psychiatry
- Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal
- (2018) Andrew S Huhn et al. PAIN MEDICINE
- Neuromodulation of orexin neurons reduces diet-induced adiposity
- (2017) A N Zink et al. INTERNATIONAL JOURNAL OF OBESITY
- Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction
- (2017) Yao-Chang Chiang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
- (2017) Akira Kuriyama et al. SLEEP MEDICINE REVIEWS
- Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food
- (2016) Rémi Martin-Fardon et al. ADDICTION BIOLOGY
- Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil
- (2015) Kirsten A. Porter-Stransky et al. ADDICTION BIOLOGY
- Orexin A-mediated AKT signaling in the dentate gyrus contributes to the acquisition, expression and reinstatement of morphine-induced conditioned place preference
- (2015) Sui-Jun Guo et al. ADDICTION BIOLOGY
- Chronic Opioid Use and Central Sleep Apnea
- (2015) Denis Correa et al. ANESTHESIA AND ANALGESIA
- Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: Vulnerability to relapse to heroin-seeking in rats
- (2015) Yan Zhou et al. PHYSIOLOGY & BEHAVIOR
- Sleep disturbances and pain among individuals with prescription opioid dependence
- (2014) Emily E. Hartwell et al. ADDICTIVE BEHAVIORS
- Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators
- (2014) Anthony L Gotter et al. BMC NEUROSCIENCE
- Compulsive-Like Responding for Opioid Analgesics in Rats with Extended Access
- (2014) Carrie L Wade et al. NEUROPSYCHOPHARMACOLOGY
- Hypocretin Receptor 2 Antagonism Dose-Dependently Reduces Escalated Heroin Self-Administration in Rats
- (2014) Brooke E Schmeichel et al. NEUROPSYCHOPHARMACOLOGY
- Escalation of drug self-administration as a hallmark of persistent addiction liability
- (2013) Scott Edwards et al. BEHAVIOURAL PHARMACOLOGY
- The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
- (2013) Anthony L Gotter et al. BMC NEUROSCIENCE
- Opioid Withdrawal Syndrome: Emerging Concepts and Novel Therapeutic Targets
- (2013) Ashish K. Rehni et al. CNS & Neurological Disorders-Drug Targets
- The applications of Vitamin E TPGS in drug delivery
- (2013) Yuanyuan Guo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System
- (2013) Andrew D. Krystal et al. JOURNAL OF CLINICAL PSYCHIATRY
- N-(2-methyl-6-benzoxazolyl)-N′-1,5-naphthyridin-4-yl urea (SB334867), a hypocretin receptor-1 antagonist, preferentially prevents ethanol seeking: comparison with natural reward seeking
- (2012) Rémi Martin-Fardon et al. ADDICTION BIOLOGY
- Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking
- (2012) Rachel J. Smith et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Role of orexin/hypocretin in conditioned sucrose-seeking in rats
- (2012) Angie M. Cason et al. PSYCHOPHARMACOLOGY
- The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors
- (2012) Géraldine M. Mang et al. SLEEP
- Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial
- (2011) Sudie E. Back et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin1 receptors
- (2010) B Jupp et al. BRITISH JOURNAL OF PHARMACOLOGY
- Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
- (2010) Christopher D. Cox et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of orexin/hypocretin in reward-seeking and addiction: Implications for obesity
- (2010) Angie M. Cason et al. PHYSIOLOGY & BEHAVIOR
- Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states
- (2009) M. Hondo et al. Acta Physiologica
- Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol–preferring Sprague–Dawley rats
- (2009) David E. Moorman et al. ALCOHOL
- Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction
- (2009) Gary Aston-Jones et al. BRAIN RESEARCH
- Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking
- (2009) Rachel J. Smith et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Orexin A/Hypocretin-1 Selectively Promotes Motivation for Positive Reinforcers
- (2009) S. L. Borgland et al. JOURNAL OF NEUROSCIENCE
- Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
- (2009) Roger Chou et al. JOURNAL OF PAIN
- Stimuli Linked to Ethanol Availability Activate Hypothalamic CART and Orexin Neurons in a Reinstatement Model of Relapse
- (2007) Christopher V. Dayas et al. BIOLOGICAL PSYCHIATRY
- Non-prescribed use of pain relievers among adolescents in the United States
- (2007) Li-Tzy Wu et al. DRUG AND ALCOHOL DEPENDENCE
- Sleep-Disordered Breathing and Chronic Opioid Therapy
- (2007) Lynn R. Webster et al. PAIN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started